Target intelligence / Profile preview

Microbiota

Molecular classification
Other
01

Overview

Microbiota refers to the community of microorganisms—including bacteria, archaea, fungi, protists, and viruses—that exist within a specific environment or host, such as the human gut, skin, or respiratory tract[1][5]. In humans, the microbiota is essential for maintaining physiological homeostasis, particularly influencing nutrition, metabolism, immune modulation, colonization resistance against pathogens, vitamin production, and even communication along the gut-brain axis[1][5][9]. Dysbiosis, or disruption of the normal microbiota, is increasingly recognized as a contributor to a wide variety of diseases, including infections, inflammatory and autoimmune conditions, metabolic disorders, cardiovascular diseases, neurodegenerative diseases, and cancer[5][6][8]. While not a single molecular target, the modulation of microbiota composition—using probiotics, prebiotics, antibiotics, bacteriophages, or fecal microbiota transplantation—represents a novel and evolving area of therapeutic intervention, albeit with significant complexity and safety considerations[2][6][8].

Other names
Human microbiotaGut microbiotaCommensal microbiotaResident microbiotaNormal floraHost-associated microbial communityMicroflora
02

Mechanism of action

Restoration or alteration of microbial community diversity/composition; Suppression of pathogenic species (subtractive therapy); Stimulation of beneficial commensals (additive therapy); Modulation of host immune response via microbial metabolites; Competitive exclusion/colonization resistance; Reestablishment of homeostasis in dysbiosis

03

Biological functions

Metabolic homeostasisImmune response modulationColonization resistance (protection against pathogens)Fermentation of food components and energy harvestProduction of micronutrients/vitaminsRegulation of gut-brain axisHormonal regulationEpithelial barrier maintenance
04

Disease associations

InflammationCardiovascular diseaseCancerInfection (e.g., Clostridioides difficile)Autoimmune disease (e.g., inflammatory bowel disease, multiple sclerosis)Neurodegenerative diseaseMetabolic disease (e.g., diabetes, obesity)Other
05

Safety considerations

Individual microbiome variabilityUnpredictable ecological effects of interventionsPotential for transferring or expanding pathogenic speciesRisk of adverse immune reactions (e.g., to FMT)Antibiotic resistance spreadDifficulty in precise mechanistic targetingIncompletely understood long-term outcomes
06

Interacting drugs

Probiotics (live beneficial bacteria, e.g., Lactobacillus, Bifidobacterium)

5 more in the full profile.

07

Biomarkers

Microbial taxonomic composition (16S rRNA, metagenomics)Specific microbial species abundanceShort-chain fatty acid levels (butyrate, acetate, propionate)Markers of dysbiosis (ratio of Firmicutes to Bacteroidetes, etc.)Microbial functional gene profiles

Beyond the preview

Go deeper on Microbiota.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbiota.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call